[HTML][HTML] Systematic review and meta-analysis: analysis of variables influencing the interpretation of clinical trial results in NAFLD
J Ampuero, R Gallego-Durán, D Maya-Miles… - Journal of …, 2022 - Springer
Background NAFLD clinical trials have shown suboptimal results, particularly for liver
fibrosis, despite the robust preclinical drug development. We aimed to assess the …
fibrosis, despite the robust preclinical drug development. We aimed to assess the …
Systematic review and meta-analysis: analysis of variables influencing the interpretation of clinical trial results in NAFLD
J Ampuero, R Gallego-Durán… - Journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Background NAFLD clinical trials have shown suboptimal results, particularly for liver
fibrosis, despite the robust preclinical drug development. We aimed to assess the …
fibrosis, despite the robust preclinical drug development. We aimed to assess the …
[HTML][HTML] Systematic review and meta-analysis: analysis of variables influencing the interpretation of clinical trial results in NAFLD
J Ampuero, R Gallego-Durán… - Journal of …, 2022 - ncbi.nlm.nih.gov
Background NAFLD clinical trials have shown suboptimal results, particularly for liver
fibrosis, despite the robust preclinical drug development. We aimed to assess the …
fibrosis, despite the robust preclinical drug development. We aimed to assess the …
Systematic review and meta-analysis: analysis of variables influencing the interpretation of clinical trial results in NAFLD.
J Ampuero, R Gallego-Durán… - Journal of …, 2022 - europepmc.org
Background NAFLD clinical trials have shown suboptimal results, particularly for liver
fibrosis, despite the robust preclinical drug development. We aimed to assess the …
fibrosis, despite the robust preclinical drug development. We aimed to assess the …
Systematic review and meta-analysis: analysis of variables influencing the interpretation of clinical trial results in NAFLD
J Ampuero, GD Rocío, D Maya-Miles… - Journal of …, 2022 - search.proquest.com
Background NAFLD clinical trials have shown suboptimal results, particularly for liver
fibrosis, despite the robust preclinical drug development. We aimed to assess the …
fibrosis, despite the robust preclinical drug development. We aimed to assess the …
Systematic review and meta-analysis: analysis of variables influencing the interpretation of clinical trial results in NAFLD
J Ampuero, R Gallego-Durán, D Maya-Miles… - 2022 - digital.csic.es
[Results] Twenty-seven randomized clinical trials were included. The pooled efficacy for
NASH resolution receiving experimental therapy was 19%(95% CI 15–23; I2 96.2%) …
NASH resolution receiving experimental therapy was 19%(95% CI 15–23; I2 96.2%) …
[PDF][PDF] Systematic review and meta-analysis: analysis of variables influencing the interpretation of clinical trial results in NAFLD
J Ampuero, R Gallego-Durán, D Maya-Miles… - J Gastroenterol, 2022 - core.ac.uk
Background NAFLD clinical trials have shown suboptimal results, particularly for liver
fibrosis, despite the robust preclinical drug development. We aimed to assess the …
fibrosis, despite the robust preclinical drug development. We aimed to assess the …
Systematic review and meta-analysis: analysis of variables influencing the interpretation of clinical trial results in NAFLD.
J Ampuero, R Gallego-Durán… - Journal of …, 2022 - europepmc.org
Background NAFLD clinical trials have shown suboptimal results, particularly for liver
fibrosis, despite the robust preclinical drug development. We aimed to assess the …
fibrosis, despite the robust preclinical drug development. We aimed to assess the …